FISH analysis of our cohort revealed PTEN hemizygous deletions in 5.5% (5/90) of all cases, which is in contrast to the reported prevalence of PTEN loss in about 20% of primary prostate cancers [7, 8, 10]. The gene discussed is PTEN; the disease is prostate cancer.